Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Debunking Myths in the US Healthcare System
Top Ten Searches
gynecomastia empyema henoch–schönlein otitis media dyspnea jaundice ventricle lyme immunodeficiency coolingYour Article Summary
See Latest ArticlesComplete and sustained remission of juvenile dermatomyositis resulting from aggressive treatment
Arthritis & Rheumatism, 06/05/09
Kim S et al. – Findings suggest that aggressive treatment of juvenile dermatomyositis (DM) aimed at achieving rapid, complete control of muscle weakness and inflammation improves outcomes and reduces disease-related complications, leading into prolonged, medication-free remission within a median of 38 months from the time of diagnosis.
Methods- An assessment of the time needed to achieve sustained, medication-free remission in pts with juvenile DM receiving a stepwise, aggressive treatment protocol
- 49 children with juvenile DM received standardized therapy with steroids and methotrexate
- If a pt's strength or muscle enzyme levels did not normalize with this initial therapy, additional medications were added in rapid succession to the treatment regimen
- Primary outcome measure: time to complete remission
- Additional outcome measures: onset of calcinosis, effect of treatment on height, and complications resulting from medications
- 49 pts were followed up for a mean of 48 mo
- All but 1 patient received ≥2 medications simultaneously
- Transient localized calcifications occurred in 8%, and 4% additional had persistent calcinosis
- Despite the aggressive therapy, complications associated with treatment were mild and were primarily attributable to steroids
- No persistent effect on longitudinal growth was observed
- A complete, medication-free remission was achieved in 28 pts
- Median time to achievement of CR was 38 mo
- None of these pts experienced a disease flare that required resumption of medications during the subsequent period of observation
Today in Pediatric Ortho/Rheum...keeping you current
Receive free subspecialty "5-minute updates" via email
Prognosis following neonatal brachial plexus palsy: an evidence-based review
Journal of Children's Orthopaedics, 11/06/09
Imaging of Back Pain in Children
American Journal of Neuroradiology, 11/23/09
The robust association between childhood physical abuse and osteoarthritis in adulthood: Findings from a representative community sample
Arthritis Care and Research , 11/05/09
Sponsor
Article Search
Sponsor
Sponsor